Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease
Source
Cardiovascular diabetology - ISSN 1475-2840-24:1 (2025) p. 1-11
Reply to: "Correspondence on "Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD""
Source
Journal of hepatology - ISSN 0168-8278-83:1 (2025) p. e21-e22
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
Source
JHEP Reports - ISSN 2589-5559-7:6 (2025) p. 1-16
MASH to cirrhosis : bridging the gaps in MASLD management
Source
Acta clinica Belgica - ISSN 1784-3286-79:6 (2025) p. 441-450
An unusual case of acute cholestatic hepatitis : visceral leishmaniasis with secondary haemophagocytic lymphohistiocytosis
Source
Acta gastro-enterologica belgica - ISSN 1784-3227-88:1 (2025) p. 78-84